2m 2m 2m 2m 2m 2m 2m
TONIX PHARM HLD (TNXP)
NASDAQ
$12.67+$0.12 (+0.96%)
Price as of Aug 21, 2026 7:43 PM EDT- $215.2MMarket Cap
- -66.96%1-Year Change
- BiotechnologyIndustry
TONIX PHARM HLD (TNXP)
$12.67+$0.12 (+0.96%)
TNXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.55 | ||
Change | +$0.16 (+1.29%) | ||
Open | $12.57 | ||
High | $12.82 | ||
Low | $12.52 | ||
Previous Close | $12.39 | ||
Volume | 369,683 | ||
30-Day Average Volume | 469,066 | ||
1-Week Change | -1.26% | ||
1-Month Change | 8.56% | ||
1-Year Change | -66.96% | ||
3-Year Change | -99.59% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 17.2M | ||
Total Assets | $254.1M | ||
Market Cap | $215.2M | ||
Enterprise Value | $39.0M | ||
Period: QTR TTM FY | |||
Revenue | $13.5M | ||
Net Income | -$40.6M | ||
Free Cash Flow | -$42.8M | ||
EBIT | -$40.6M | ||
EBITDA | -$39.9M | ||
Net Working Capital | $172.6M | ||
EPS | -$2.44 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 02/05/2025 | ||
Earnings & Revenue